On the 28th number of Frontiere - the communication channel of Politecnico di Milano for all those who are interested in research - it talks about MINERVA, a technological device patented by the Politecnico di Milano that aims to revolutionize preclinical research.

The MINERVA device was created within the European frontier project with the same name, funded by the European Research Council (ERC) and led by Carmen Giordano. The goal of the project was ambitious: to create a technological platform capable of replicating the molecular mechanisms that regulate the so-called “microbiota-gut-brain axis”. This two-way communication between the brain and the gut flora, known as microbiota, is crucial for our body’s functioning, but the details of its interactions still remain largely unknown.

> MINERVA, the device that reproduces cellular models for advanced studies and personalized therapies